Saudi Vision 2030 · Strategic Alignment

Cardiac
Intelligence
for the Kingdom.

EchoVest as national-scale cardiac infrastructure — accessible, AI-enabled, and sovereign. From the towers of Riyadh to the plains of Arafat, every heart, every region, every pilgrim.

رؤية ٢٠٣٠
من أجل قلب كل مواطن
Vision 2030 Health
$0B
Healthcare investment committed by the Kingdom
Section I

Why this partnership, why now.

Three forces converge in 2026: regulatory openness, infrastructure readiness, and a humanitarian deployment scenario unmatched anywhere on earth.

SFDA regulatory modernization

The Saudi Food and Drug Authority has accelerated medical device approval pathways with mutual recognition for FDA-cleared devices. EchoVest's 510(k) filing K254143 (Dec 2025) positions it for expedited SFDA registration — Saudi market entry by 2027.

National digital health infrastructure

Saudi Arabia's national health information exchange and cloud-native EMR rollout create ready infrastructure for AI-powered diagnostics. EchoVest integrates natively with cloud systems, DICOM standards, and interoperable reporting frameworks.

Hajj health mandate

The Ministry of Hajj and Umrah has prioritized pilgrim health screening and emergency cardiac readiness. The annual convergence of 2M+ pilgrims under extreme heat represents an urgent need uniquely suited to wearable, AI-assisted cardiac imaging.

Section II

A cardiovascular crisis requiring sovereign solutions.

Saudi Arabia carries one of the world's highest cardiovascular disease burdens. Vision 2030 mandates a 30% reduction in CVD mortality and 95% primary care access. The math demands scale only AI-led screening can deliver.

0%
of all KSA deaths from cardiovascular disease
0%
national diabetes prevalence
0%
obesity rate among adults

EchoVest enables scalable cardiac screening across 13 administrative regions, dramatically reducing dependency on the global sonographer shortage and supporting Saudization workforce mandates from day one.

Section III

Aligned with Saudi digital health strategy.

The Kingdom's digital health agenda prioritizes AI-first diagnostics, cloud-native platforms, and interoperable health records. EchoVest is natively designed for this architecture.

SFDA registration is accelerated by the FDA 510(k) predicate pathway, enabling market entry as early as 2027 — fully synchronized with Vision 2030's mid-decade health milestones.

  • AI-powered diagnostic engine, on-device & cloud
  • HIPAA + SFDA dual-compliant reporting
  • DICOM-native, EMR-interoperable
  • Saudization-ready operator workflow
  • Edge & remote-monitoring architecture
Section IV

Regulatory pathway to the Saudi market.

FDA 510(k) submission K254143 was filed December 22, 2025 under Class II Medical Device classification (21 CFR 892.1570). The route to SFDA registration follows an accelerated mutual-recognition pathway.

December 2025

FDA 510(k) Filed

Submission K254143 under Class II classification — passive ultrasound stabilization predicate (K092164).

✓ Completed
Mid-2026

FDA Testing

Substantial equivalence determination expected, opening the regulatory bridge for international filings.

In Review
Target 2027

SFDA Registration

Accelerated pathway via mutual recognition. Saudi market authorization unlocks national deployment.

Planned
Section V

Phased national deployment.

A three-year glide path from metropolitan pilot to mass-pilgrimage operations to full national infrastructure across all 13 administrative regions.

2028

Pilot · Riyadh & Jeddah

Three to five hospital deployments across the Kingdom's two primary metropolitan centers. Clinical validation under SFDA oversight, real-world workflow integration, and Saudization operator training.

2029

Hajj Cardiac Screening

Mass-screening deployment at Mina and Arafat — a humanitarian mission scaled to 2M+ pilgrims annually, with remote cardiologist oversight from Riyadh command centers.

2030

National Rollout

50+ facilities across all 13 KSA regions. Full national cardiac imaging infrastructure, integrated with the national health information exchange and accessible to every citizen.

Section VI

Economic impact at sovereign scale.

EchoVest delivers structural cost advantages over traditional echocardiography while expanding capacity. These projections reflect system design specifications; clinical validation is pending.

Per-Facility Scan Throughput · Traditional vs. EchoVest
0 /day
Traditional
Echo Suite
0 /day
EchoVest
Year 1
0 /day
EchoVest
Year 2
0 /day
EchoVest
Optimized
~0%
Estimated per-scan cost reduction vs. traditional echocardiography
0×
Projected increase in scan volume capacity per facility
0 sec
Diagnostic workflow from vest application to report
Section VII

The Hajj health opportunity.

2 million+ annual Hajj pilgrims undergo extreme heat and physical exertion, creating elevated cardiac risk at unprecedented scale. Recent Hajj seasons have underscored the cardiac toll of mass-pilgrimage conditions, with cardiac events representing the leading cause of medical emergencies among pilgrims.

EchoVest enables mass cardiac screening at Mina and Arafat — a deployment scenario no existing device can match. Beyond Hajj, a national cardiac imaging network positions EchoVest as foundational health infrastructure across 13 KSA regions.

Co-Develop the Hajj Program
Section VIII

Institutional alignment.

A constellation of sovereign institutions positioned to convene EchoVest into the Kingdom's healthcare architecture.

Saudi MOH
Saudi FDA · SFDA
NEOM Health
King Faisal Specialist
Saudi Health Council
Hajj & Umrah Ministry
PIF · Public Investment
KAUST
Begin the Conversation

Co-architect the future of cardiac sovereignty.

EchoVest is open to institutional partnership across pilots, technology transfer, national screening infrastructure, and Hajj health deployment. Vision 2030 is the canvas. Let us paint it together.